A Commitment to Precision. A Legacy of Trust.
MGA Drugs Private Limited
MGA Drugs Private Limited is a WHO-GMP certified and EU-GMP compliant pharmaceutical manufacturing company Corportate in Zirakpur, Punjab, India. Established as part of the MGA Group — which began its pharmaceutical manufacturing journey as Sunvet Pharma Pvt Ltd in 2006 — the company has grown over 18+ years into a multi-unit manufacturing powerhouse with a strong presence across both (human pharmaceutical) and veterinary injectable segments.
We specialise in the manufacturing of sterile small-volume parenterals (SVP), solid oral dosage forms, and dry syrups — covering a comprehensive range of cephalosporins, beta-lactams, carbapenems, and general antibiotic formulations. (Our products are supplied to government institutions, public sector hospitals, private pharmaceutical companies, and international distributors across more than 20 countries.)
What sets MGA Drugs apart is our unwavering commitment to quality at every stage — from raw material procurement and in-process manufacturing to QA release and final dispatch. Our facilities are regularly inspected by national and international regulatory authorities, and we have consistently maintained a clean compliance record across all three of our production units.
When we founded this company, we had one simple belief: that every patient who receives a medicine manufactured by us deserves the very best. Not the best that is convenient, or the best that is cost-effective — the absolute best that science, infrastructure, and human dedication can deliver. That belief has not changed in over 18 years. It has only deepened.
Quality is not a department or a checklist at MGA Drugs. It is a commitment embedded in every process, every batch, and every decision we make.
Today, MGA Drugs stands as a WHO-GMP certified and EU-GMP compliant manufacturer serving healthcare institutions and partners across more than 20 countries.
Mr. Manik Arora
Managing Director, MGA Drugs Private LimitedPurpose, Vision & Values
Everything we do at MGA Drugs is rooted in principles established at our founding and refined over 18+ years of manufacturing. These principles guide how we manufacture, how we engage with partners, and how we ensure quality in every batch.
18+ Years of
Pharmaceutical Excellences
From a single sterile manufacturing unit in Himachal Pradesh to a multi-facility pharmaceutical group supplying 20+ countries worldwide.
The Foundation of Sunvet Pharma Manufacturing
The journey began with the establishment of Sunvet Pharma’s manufacturing operations, driven by a vision to produce reliable and affordable pharmaceutical products. In the early years, the focus was on creating a strong technical foundation, building a skilled workforce, and implementing disciplined manufacturing practices.
GMP and GLP Certification
A major milestone was achieved with the successful implementation of Good Manufacturing Practices (GMP). This certification reflected our commitment to maintaining consistent product quality, proper documentation, validated processes, and controlled manufacturing environments. Achieving GMP standards strengthened customer confidence and enhanced our ability to serve regulated markets. It also marked the beginning of a culture where quality became an integral part of every manufacturing activity.
Expansion into Cephalosporin Injectables
Recognizing the growing demand for Cephalosporin injectables and Beta-Lactam Injectable , our company expanded into Setting up. Beta-Lactam , Cephalosporin DPI lines This required the development of specialized sterile areas, controlled cleanroom environments, and advanced aseptic processing systems. The expansion significantly enhanced our manufacturing capabilities and product portfolio. It also positioned the organization as a stronger player in the injectable segment, with greater technical and regulatory competence.
OSD Cephalosporin and Beta-Lactam Manufacturing Line (GMP-GLP)
The organization further diversified by entering the Oral Solid Dosage (OSD) Beta-Lactam Cephalosporin segment. Modern manufacturing equipment and quality-driven processes were introduced for tablets, capsules and Dry Syrup. This expansion allowed us to offer a broader range of pharmaceutical formulations while maintaining the same rigorous quality standards followed in injectables
Incorporation of MGA Drugs Pvt. Ltd.
In 2023, MGA Drugs Pvt. Ltd. was officially incorporated with a clear vision to build a global pharmaceutical export business. The company was founded to combine manufacturing strength with international market expansion and strategic partnerships.
First Export Order
The year 2024 marked the beginning of our international commercial journey with the successful execution of our first export order. This achievement validated the quality of our products, the reliability of our manufacturing systems, and the strength of our documentation and regulatory support.
Expansion into Two Advanced Manufacturing Units
All facilities achieved WHO-GMP compliance following successful independent audits. International reach expanded to 20+ countries across Africa, the Middle East, CIS, South Asia, and Southeast Asia. The company continues to expand its regulatory registrations across new export markets.
WHO-GMP Certification of MGA DRUGS PRIVATE LIMITED
MGA Drugs continues to invest in new product development, expanded regulatory capabilities for export markets, manufacturing technology upgrades, and talent development — with an unwavering focus on making quality medicines accessible across every market that needs them.
August 2026 —Setup of the Third WHO-GMP OSD Unit
A new chapter began with the launch of our Third Manufacturing Unit dedicated to Oral Solid Dosage (OSD) – Cephalosporin & Beta-Lactam products. Today, MGA Drugs Pvt. Ltd. stands as a growing pharmaceutical company backed by 18+ years of manufacturing experience With specialized facilities for Small Volume Parenterals and oral solid dosage forms, the organization is committed to delivering high-quality, compliant, and affordable medicines to global markets.